Question: I have recently been diagnosed with sciatica and I am finding it difficult to do any exercise. My usual form of ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Vertex is studying suzetrigine in sciatica; in a phase II trial, the drug showed a statistically significant change in lumbosacral radiculopathy pain from baseline, similar to the reduction in the ...

Other potential causes include fractures, arthritis, and cervical radiculopathy. If you have mild to moderate pain, you can try using home remedies such as R.I.C.E., stretches, and OTC medications ...

prescribed a Medrol dosepak for presumed radiculopathy. Over the next few weeks her left leg pain and weakness worsened. Her primary care physician ordered a magnetic resonance imaging (MRI ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...